Navigation Links
CRi Announces Nuance 2, the Next-Generation Multispectral Imaging System for Brightfield and Fluorescent-Based Microscopy
Date:12/10/2007

WOBURN, Mass., Dec. 10 /PRNewswire/ -- Cambridge Research & Instrumentation, Inc. (CRi) announces the launch of Nuance 2, the affordable, breakthrough system that converts any brightfield or fluorescent microscope into a multispectral imaging workstation. For multispectral imaging analysis of a larger specimens, such as embryos, zebrafish, plants, tissue culture and microtiter plates, the Nuance 2 can be mounted onto a fluorescent macroscope. The Nuance 2 system will be showcased at the upcoming San Antonio Breast Cancer Symposium from December 13th through December 16th in San Antonio, Texas.

The sleekly designed Nuance 2 features new analytical software providing the user with enhanced spectral unmixing tools and more efficient CCD cooling for better low-light imaging. Spectral library building is now easier, using the Real Component Analysis(TM) (RCA) algorithm to automatically identify spectral signatures and the new Compute Spectra(TM) feature to properly identify true spectral signatures when combined or overlapping. Nuance sensitivity has been improved allowing discrimination of co-localized markers, even when present in different amounts, and reports the relative amounts of each marker and the percentage of each co-localized marker within the sample. At the heart of the Nuance 2 is the Flex(TM) liquid crystal tunable filter (LCTF) which provides fast, accurate spectral imaging from 420 to 720 nm (VIS model) and 500 to 950 nm (GNIR model), covering the full range of available chromogenic dyes and in vitro fluorophores.

"We are very excited about the Nuance 2 Multispectral Imaging System," says James Mansfield, Director of Multispectral Imaging Systems at CRi. "From its new industrial design, optimized optics and user-friendly software tools, this system was designed and developed with the customers' needs in mind. Along with our award winning Maestro(TM) In Vivo imaging systems, CRi offers a full spectrum of imaging solutions for our customers."

CRi, a Boston-based biomedical imaging company, provides innovative optical imaging solutions for customers for more than 20 years. CRi's multidisciplinary team is dedicated to working with academic and commercial customers to provide high-value solutions. CRi provides comprehensive imaging and analysis solutions that enable the user to investigate and characterize biological phenotypes while preserving spatial context. With over 80 patents issued and pending, CRi's solution platforms encompass sub-cellular, cellular and whole animal applications. CRi innovations are being utilized around the world to enable new breakthroughs in research, health and medicine. For more information visit our website at http://www.cri-inc.com or contact:

David Daniels, Ph.D.

Director of Marketing

CRi

35-B Cabot Road, Woburn, MA 01801 USA

Tel: 1-781-935-9099, extension 149

E-mail: ddaniels@cri-inc.com


'/>"/>
SOURCE Cambridge Research & Instrumentation, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Atlanta, it seems everyone has a chance to express their ... expressive and dynamic community unlike any other. The businesses that ... With their newest salon in ... on that tradition with a unique, fresh approach to head ... the newest of 13 nationwide locations, each of them well-situated ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life Sciences ... line of oncolytic vaccinia viruses for virotherapy research. ... part of Genelux,s proprietary, vaccinia virus-based technology platform ... to enter into a partnership with Genelux to ... vaccinia viruses for use in research," said Dr. ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... that in a published evaluation of multiple immunoassay-based threat detection technologies by ... Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have ...
(Date:2/23/2017)... ... February 23, 2017 , ... Today, ... cortisol, CRP, adiponectin, uric acid, and/or other biomarkers or SNPs of interest) using ... Salimetrics’ SalivaLab , the relationship between insulin and other relevant biomarkers can ...
Breaking Biology Technology:
(Date:2/8/2017)... About Voice Recognition Biometrics Voice recognition biometrics ... a stored voiceprint template. Acoustic features of an ... are compared to distinguish between individual voices. Voice ... PCs already have a microphone and can authenticate ... are most likely to be deployed in telephone-based ...
(Date:2/8/2017)... , Feb. 7, 2017 The biometrics ... by the confluence of organizations, desires to better ... knowledge-based systems (password and challenge questions), biometrics is ... government systems. The market is driven by use ... between consumer and enterprise uses cases, with consumer-facing ...
(Date:2/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... at the LEERINK Partners 6th Annual Global Healthcare Conference ... February 15, 2017 at 10 a.m. Eastern Time. ... be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
Breaking Biology News(10 mins):